SCHEMBL9997303

SCHEMBL9997303

N#Cc1cccc(S(=O)(=O)Nc2cccc(C(=O)O)c2O)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GLO1 Q04760 1/20 0.54
SLC40A1 Q9NP59 1/20 0.54
ACLY P53396 3/20 0.53
MEN1 O00255 3/20 0.51
KMT2A Q03164 3/20 0.51
KDM4E B2RXH2 1/20 0.51
POLB P06746 1/20 0.51
KAT6A Q92794 1/20 0.51
PGAM1 P18669 1/20 0.51
GAA P10253 2/20 0.50
PGR P06401 1/20 0.50
MCL1 Q07820 1/20 0.50
CCKBR P32239 1/20 0.50
PTGES2 Q9H7Z7 1/20 0.50
CCR2 P41597 2/20 0.49
RXFP1 Q9HBX9 1/20 0.49
TRIM24 O15164 1/20 0.47
MAPT P10636 1/20 0.47
CRBN Q96SW2 1/20 0.47
PFKFB3 Q16875 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28637555 0.82 KMT2A (0.58) ACLYMEN1KMT2AKDM4EPOLB
SCHEMBL28653065 0.81 PFKFB3 (0.48) ACLYMEN1KMT2AKDM4EPOLB
SCHEMBL21218351 0.79 SLC40A1 (0.53) GLO1SLC40A1ACLYKDM4EKAT6A
SCHEMBL9997060 0.79 PFKFB3 (0.58) MEN1KMT2APGRMCL1PFKFB3
SCHEMBL3983954 0.78 METAP2 (0.72) GLO1SLC40A1ACLYPGAM1PGR
SCHEMBL9997386 0.77 ALDH1A1 (0.62) ACLYMEN1KMT2AKDM4EPOLB
SCHEMBL9996881 0.77 ALDH1A1 (0.62) GLO1MEN1KMT2AKDM4EPOLB
SCHEMBL14075357 0.75 PGR (0.59) ACLYMEN1KMT2AKDM4EKAT6A
SCHEMBL17538556 0.75 ALDH1A1 (0.63) GLO1ACLYMEN1KMT2AKDM4E
SCHEMBL28637411 0.75 ACLY (0.55) ACLYMEN1KMT2AKDM4EPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011161201-A1 BISARYLSULFONAMIDES USEFUL AS KINASE INHIBITORS IN THE TREATMENT OF INFLAMMATION AND CANCER KANCERA AB (SE) 2011-12-29 WO disclosed